DJIA 16,528.03 -114.98 -0.69%
NASDAQ 4,776.51 -51.82 -1.07%
S&P 500 1,972.18 -16.69 -0.84%
market minute promo

Epizyme (NASDAQ: EPZM)



company name or ticker

Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog

Excitement For Epizyme

5 Predictions for Biotechnology Stocks in 2015

Celgene Corp, Alkermes, GW Pharmaceuticals, Gilead Sciences, and Hospira should all be on investors radar in 2015.

Primecap Exceeds 5% Threshold In Shutterfly, 3 Other Companies

Epizyme: The Ugly Duckling Of The 2014 Biotech Rally?

Commit To Purchase Epizyme At $15, Earn 11.5% Annualized Using Options

Epizyme: Shares Oversold On Mixed Data From Early Studies

RSI Alert: Epizyme (EPZM) Now Oversold

3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't

Gilead Sciences, Celgene, and Biogen all have rock-solid financials, but none are likely to pay a dividend anytime soon.

Epizyme Gains on Positive Phase I Data on EPZ-6438 - Analyst Blog

See More Articles...